Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Year in Review: Physicians Pick the Biggest News of 2019

News Features

Year in Review: Physicians Pick the Biggest News of 2019

TCTMD News Team

December 30, 2019

FDA Gives Rivaroxaban Another VTE-Related Indication

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

October 14, 2019

TCTMD’s Top 10 Most Popular Stories for August 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2019

August 30, 2019

News Industry News

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

July 23, 2019

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

News Daily News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

July 16, 2019

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

News Daily News

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

May 14, 2019

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

TCTMD’s Top 10 Most Popular Stories for April 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2019

May 01, 2019

PCSK9 Inhibitor Alirocumab Receives Expanded Indication for CV Event Reduction

News Daily News

PCSK9 Inhibitor Alirocumab Receives Expanded Indication for CV Event Reduction

Michael O'Riordan

April 29, 2019

FDA Grants Approval to TherOx for Supersaturated Oxygen Therapy in LAD STEMI

News Daily News

FDA Grants Approval to TherOx for Supersaturated Oxygen Therapy in LAD STEMI

April 04, 2019

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

News Daily News

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

Michael O'Riordan

February 22, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.